Cargando…
Serum free thiols in type 2 diabetes mellitus: A prospective study
AIMS: Oxidative stress is a driver in the development of type 2 diabetes (T2DM) complications. As thiols (R-SH) are oxidized by reactive oxygen and sulfur species, circulating concentrations may directly reflect systemic redox status. We hypothesized that high serum R-SH concentrations are a reflect...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407140/ https://www.ncbi.nlm.nih.gov/pubmed/30899672 http://dx.doi.org/10.1016/j.jcte.2019.100182 |
_version_ | 1783401479691829248 |
---|---|
author | Schillern, Emmelien E.M. Pasch, Andreas Feelisch, Martin Waanders, Femke Hendriks, Steven H. Mencke, Rik Harms, Geert Groenier, Klaas H. Bilo, Henk J.G. Hillebrands, Jan-Luuk van Goor, Harry van Dijk, Peter R. |
author_facet | Schillern, Emmelien E.M. Pasch, Andreas Feelisch, Martin Waanders, Femke Hendriks, Steven H. Mencke, Rik Harms, Geert Groenier, Klaas H. Bilo, Henk J.G. Hillebrands, Jan-Luuk van Goor, Harry van Dijk, Peter R. |
author_sort | Schillern, Emmelien E.M. |
collection | PubMed |
description | AIMS: Oxidative stress is a driver in the development of type 2 diabetes (T2DM) complications. As thiols (R-SH) are oxidized by reactive oxygen and sulfur species, circulating concentrations may directly reflect systemic redox status. We hypothesized that high serum R-SH concentrations are a reflection of a favourable redox status and may therefore positively associate with disease status. METHODS: R-SH were measured in serum of 943 T2DM outpatients (55% males, 65 years and HbA1c of 6.7% (50 mmol/mol)) with a follow-up period of 1.2 years. RESULTS: In the highest R-SH tertile patients were younger, more often men, had less microvascular complications, lower HbA1c and were more often treated nutritionally or with oral glucose-lowering drugs. Age- and sex adjusted hazard ratios for developing micro-, macro- or any complication plus death were 0.994, 0.992 and 0.993: even after adjustment for potential confounders. The Harrell’s C statistic to predict microvascular complications or any complication plus death was higher in the models with R-SH than in those without R-SH. CONCLUSIONS: Although R-SH concentrations were associated with a favourable disease status, it did not add to the predictive capacity for long-term complications. Based on the current data R-SH seems unsuitable as a prognostic marker in T2DM. |
format | Online Article Text |
id | pubmed-6407140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-64071402019-03-21 Serum free thiols in type 2 diabetes mellitus: A prospective study Schillern, Emmelien E.M. Pasch, Andreas Feelisch, Martin Waanders, Femke Hendriks, Steven H. Mencke, Rik Harms, Geert Groenier, Klaas H. Bilo, Henk J.G. Hillebrands, Jan-Luuk van Goor, Harry van Dijk, Peter R. J Clin Transl Endocrinol Research Paper AIMS: Oxidative stress is a driver in the development of type 2 diabetes (T2DM) complications. As thiols (R-SH) are oxidized by reactive oxygen and sulfur species, circulating concentrations may directly reflect systemic redox status. We hypothesized that high serum R-SH concentrations are a reflection of a favourable redox status and may therefore positively associate with disease status. METHODS: R-SH were measured in serum of 943 T2DM outpatients (55% males, 65 years and HbA1c of 6.7% (50 mmol/mol)) with a follow-up period of 1.2 years. RESULTS: In the highest R-SH tertile patients were younger, more often men, had less microvascular complications, lower HbA1c and were more often treated nutritionally or with oral glucose-lowering drugs. Age- and sex adjusted hazard ratios for developing micro-, macro- or any complication plus death were 0.994, 0.992 and 0.993: even after adjustment for potential confounders. The Harrell’s C statistic to predict microvascular complications or any complication plus death was higher in the models with R-SH than in those without R-SH. CONCLUSIONS: Although R-SH concentrations were associated with a favourable disease status, it did not add to the predictive capacity for long-term complications. Based on the current data R-SH seems unsuitable as a prognostic marker in T2DM. Elsevier 2019-02-28 /pmc/articles/PMC6407140/ /pubmed/30899672 http://dx.doi.org/10.1016/j.jcte.2019.100182 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Schillern, Emmelien E.M. Pasch, Andreas Feelisch, Martin Waanders, Femke Hendriks, Steven H. Mencke, Rik Harms, Geert Groenier, Klaas H. Bilo, Henk J.G. Hillebrands, Jan-Luuk van Goor, Harry van Dijk, Peter R. Serum free thiols in type 2 diabetes mellitus: A prospective study |
title | Serum free thiols in type 2 diabetes mellitus: A prospective study |
title_full | Serum free thiols in type 2 diabetes mellitus: A prospective study |
title_fullStr | Serum free thiols in type 2 diabetes mellitus: A prospective study |
title_full_unstemmed | Serum free thiols in type 2 diabetes mellitus: A prospective study |
title_short | Serum free thiols in type 2 diabetes mellitus: A prospective study |
title_sort | serum free thiols in type 2 diabetes mellitus: a prospective study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407140/ https://www.ncbi.nlm.nih.gov/pubmed/30899672 http://dx.doi.org/10.1016/j.jcte.2019.100182 |
work_keys_str_mv | AT schillernemmelienem serumfreethiolsintype2diabetesmellitusaprospectivestudy AT paschandreas serumfreethiolsintype2diabetesmellitusaprospectivestudy AT feelischmartin serumfreethiolsintype2diabetesmellitusaprospectivestudy AT waandersfemke serumfreethiolsintype2diabetesmellitusaprospectivestudy AT hendriksstevenh serumfreethiolsintype2diabetesmellitusaprospectivestudy AT menckerik serumfreethiolsintype2diabetesmellitusaprospectivestudy AT harmsgeert serumfreethiolsintype2diabetesmellitusaprospectivestudy AT groenierklaash serumfreethiolsintype2diabetesmellitusaprospectivestudy AT bilohenkjg serumfreethiolsintype2diabetesmellitusaprospectivestudy AT hillebrandsjanluuk serumfreethiolsintype2diabetesmellitusaprospectivestudy AT vangoorharry serumfreethiolsintype2diabetesmellitusaprospectivestudy AT vandijkpeterr serumfreethiolsintype2diabetesmellitusaprospectivestudy |